Effectiveness of a Novel Therapeutic Exercise Protocol for Benign Prostatic Hyperplasia: Development and Validation of a Urinary Force Measurement Scale

Abstract

Background: Benign prostatic hyperplasia (BPH) is the most prevalent urological condition among aging men. Current pharmacological therapies offer symptomatic relief but often carry adverse effects. This study evaluated a novel, copyright-registered therapeutic exercise protocol and developed the Urinary Force Measurement Scale (UFMS) as an objective tool to measure urinary stream strength.
Methods: Forty men with clinically diagnosed BPH (prostate volume >30 cc, IPSS ≥ 8) underwent an 8-week structured exercise program targeting pelvic floor and perineal muscles, combined with diaphragmatic breathing. Primary outcome was urinary force output (UFMS, 0–4). Secondary outcomes included International Prostate Symptom Score (IPSS), residual urine volume (ultrasound), and satisfaction (VAS). Pre- and post-intervention results were compared using paired t-tests. Results: UFMS improved from 1.4 ± 0.6 to 3.0 ± 0.7 (p<0.001). IPSS decreased from 19.5 ± 4.2 to 11.3 ± 3.7 (p<0.001). Residual urine volume reduced by 28% (p<0.01). Satisfaction improved from 4.2 ± 1.1 to 8.9 ± 0.8 (p<0.001). No adverse events occurred. Conclusion: This proprietary exercise protocol significantly enhances urinary flow and alleviates LUTS in BPH patients. UFMS is a practical tool for clinical and research applications.